182 related articles for article (PubMed ID: 30184291)
1. Vaccine-preventable disease following allogeneic haematopoietic stem cell transplant in Western Australia.
Ryan AL; Kerr F; Gough H; Carter TL; Kotecha RS
J Paediatr Child Health; 2019 Mar; 55(3):343-348. PubMed ID: 30184291
[TBL] [Abstract][Full Text] [Related]
2. A survey of infectious diseases and vaccination uptake in long-term hematopoietic stem cell transplant survivors in Australia.
Dyer G; Gilroy N; Brice L; Kabir M; Gottlieb D; Huang G; Hogg M; Brown L; Greenwood M; Larsen SR; Moore J; Hertzberg M; Tan J; Ward C; Kerridge I
Transpl Infect Dis; 2019 Apr; 21(2):e13043. PubMed ID: 30585673
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplant.
Ryan AL; Wadia UD; Jacoby P; Cheung LC; Kerr F; Fraser C; Tapp H; Mechinaud F; Carolan LA; Laurie KL; Barr IG; Blyth CC; Gottardo NG; Richmond PC; Kotecha RS
Bone Marrow Transplant; 2020 Apr; 55(4):773-779. PubMed ID: 31659236
[TBL] [Abstract][Full Text] [Related]
4. Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial.
Winston DJ; Mullane KM; Cornely OA; Boeckh MJ; Brown JW; Pergam SA; Trociukas I; Žák P; Craig MD; Papanicolaou GA; Velez JD; Panse J; Hurtado K; Fernsler DA; Stek JE; Pang L; Su SC; Zhao Y; Chan ISF; Kaplan SS; Parrino J; Lee I; Popmihajlov Z; Annunziato PW; Arvin A;
Lancet; 2018 May; 391(10135):2116-2127. PubMed ID: 29856344
[TBL] [Abstract][Full Text] [Related]
5. Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Aoki T; Koh K; Kawano Y; Mori M; Arakawa Y; Kato M; Hanada R
Biol Blood Marrow Transplant; 2016 Apr; 22(4):771-775. PubMed ID: 26748161
[TBL] [Abstract][Full Text] [Related]
6. Paediatric Active Enhanced Disease Surveillance (PAEDS) 2017 and 2018: Prospective hospital-based surveillance for serious paediatric conditions.
McRae JE; Quinn HE; Saravanos GL; Carlson SJ; Britton PN; Crawford NW; Wood NJ; Marshall HS; Macartney KK;
Commun Dis Intell (2018); 2020 Jun; 44():. PubMed ID: 32536339
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of viral infections among children undergoing hematopoietic stem cell transplant: Α prospective single-center study.
Tsoumakas K; Giamaiou K; Goussetis E; Graphakos S; Kossyvakis A; Horefti E; Mentis A; Elefsiniotis I; Pavlopoulou ID
Transpl Infect Dis; 2019 Aug; 21(4):e13095. PubMed ID: 30993823
[TBL] [Abstract][Full Text] [Related]
8. Herpes zoster infection in the post-hematopoietic stem cell transplant pediatric population may be preceded by transaminitis: an institutional experience.
Berman JN; Wang M; Berry W; Neuberg DS; Guinan EC
Bone Marrow Transplant; 2006 Jan; 37(1):73-80. PubMed ID: 16247423
[TBL] [Abstract][Full Text] [Related]
9. Sociodemographic and psychological determinants of influenza vaccine intention among recipients of autologous and allogeneic haematopoietic stem cell transplant: a cross-sectional survey of UK transplant recipients using a modified health belief model.
Miller PDE; Forster AS; de Silva TI; Leonard H; Anthias C; Mayhew M; Klammer M; Paskar S; Hurst E; Peggs K; Madrigal A; Snowden JA
BMJ Open; 2018 Aug; 8(8):e021222. PubMed ID: 30093515
[TBL] [Abstract][Full Text] [Related]
10. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
[TBL] [Abstract][Full Text] [Related]
11. Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GVHD.
Hilgendorf I; Freund M; Jilg W; Einsele H; Gea-Banacloche J; Greinix H; Halter J; Lawitschka A; Wolff D; Meisel R
Vaccine; 2011 Apr; 29(16):2825-33. PubMed ID: 21345379
[TBL] [Abstract][Full Text] [Related]
12. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation.
Leung TF; Chik KW; Li CK; Lai H; Shing MM; Chan PK; Lee V; Yuen PM
Bone Marrow Transplant; 2000 Jan; 25(2):167-72. PubMed ID: 10673675
[TBL] [Abstract][Full Text] [Related]
13. Varicella zoster reactivation after hematopoietic stem cell transplant in children is strongly correlated with leukemia treatment and suppression of host T-lymphocyte immunity.
Vermont CL; Jol-van der Zijde EC; Hissink Muller P; Ball LM; Bredius RG; Vossen AC; Lankester AC
Transpl Infect Dis; 2014 Apr; 16(2):188-94. PubMed ID: 24438482
[TBL] [Abstract][Full Text] [Related]
14. Long-term survivors following autologous haematopoetic stem cell transplantation have significant defects in their humoral immunity against vaccine preventable diseases, years on from transplant.
Colton H; Greenfield DM; Snowden JA; Miller PDE; Morley NJ; Wright J; Darton TC; Evans CM; de Silva TI
Vaccine; 2021 Aug; 39(34):4778-4783. PubMed ID: 34294480
[TBL] [Abstract][Full Text] [Related]
15. Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation.
Ma CK; Blyth E; Clancy L; Simms R; Burgess J; Brown R; Deo S; Micklethwaite KP; Gottlieb DJ
Cytotherapy; 2015 Oct; 17(10):1406-20. PubMed ID: 26349000
[TBL] [Abstract][Full Text] [Related]
16. [Vaccination].
Graubner UB; Liese J; Belohradsky BH
Klin Padiatr; 2001 Sep; 213 Suppl 1():A77-83. PubMed ID: 11577366
[TBL] [Abstract][Full Text] [Related]
17. Status of immunity for vaccine--preventable diseases in children after hematopoietic stem cells transplantation.
Goździk J; Czajka H; Paradowska-Stankiewicz I; Skoczeń S; Czogała W; Krasowska-Kwiecień A; Wiecha O
Przegl Epidemiol; 2012; 66(1):93-8. PubMed ID: 22708306
[TBL] [Abstract][Full Text] [Related]
18. Molecular monitoring of adenovirus reactivation in faeces after haematopoietic stem-cell transplantation to predict systemic infection: a retrospective cohort study.
Hum RM; Deambrosis D; Lum SH; Davies E; Bonney D; Guiver M; Turner A; Wynn RF; Hiwarkar P
Lancet Haematol; 2018 Sep; 5(9):e422-e429. PubMed ID: 30172346
[TBL] [Abstract][Full Text] [Related]
19. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation.
Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
Clin Infect Dis; 2007 Mar; 44(5):625-34. PubMed ID: 17278051
[TBL] [Abstract][Full Text] [Related]
20. VaccHemInf project: protocol for a prospective cohort study of efficacy, safety and characterisation of immune functional response to vaccinations in haematopoietic stem cell transplant recipients.
Conrad A; Boccard M; Valour F; Alcazer V; Tovar Sanchez AT; Chidiac C; Laurent F; Vanhems P; Salles G; Brengel-Pesce K; Meunier B; Trouillet-Assant S; Ader F;
BMJ Open; 2019 Feb; 9(2):e026093. PubMed ID: 30772864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
